TP53 and posterior cortical atrophy: Our clinical correlation analysis with multiple public cohorts identified a total of five genes, namely, ADAMTS7, CDH1, DRD5, MGAT5, and TP53, whose mutations were significantly associated with malignant progression and adverse prognosis in PCa.